Research Interests
Study to Enhance Anti-Neuroblastoma Immune Response in Relapsed/Refractory High-Risk Neuroblastoma Using Nivolumab, Dinutuximab, and Adoptive Transfer of Activated, Allogeneic MHC-1 Mismatched NK Cells
Selected Grants
A Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmacokinetics of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis or Invasive Mucormycosis in Pediatric Subjects
Clinical TrialPrincipal Investigator · Awarded by Astellas Pharma Global Development, Inc · 2020 - 2024A multicenter study of apheresis collection of peripheral blood mononuclear (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2015 - 2020Acid Sphingomyelinase Activation in Apoptosis
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1997 - 2002External Relationships
- Gamida Cell Inc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.